Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma have?
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma has 897 citations in the OpenAlex counts ScholarIQ stores.
When was Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma published?
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma has 2021 year in the ScholarIQ index.
What is the open-access status of Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma?
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma has bronze oa status in the ScholarIQ index.
What is the DOI of Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma?
The DOI for Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma is on the source record.
What is the PMID of Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma?
The PMID for Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma is on the source record.
What is the OpenAlex record for Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma?
The OpenAlex for Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma is on the source record.